These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8703074)

  • 1. Enhanced protein C activation and inhibition of fibrinogen cleavage by a thrombin modulator.
    Berg DT; Wiley MR; Grinnell BW
    Science; 1996 Sep; 273(5280):1389-91. PubMed ID: 8703074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation of thrombin's substrate interactions using site-directed mutagenesis.
    Leung LL; Hall SW
    Trends Cardiovasc Med; 2000 Feb; 10(2):89-92. PubMed ID: 11150736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of thrombin into an anticoagulant by protein engineering.
    Gibbs CS; Coutré SE; Tsiang M; Li WX; Jain AK; Dunn KE; Law VS; Mao CT; Matsumura SY; Mejza SJ
    Nature; 1995 Nov; 378(6555):413-6. PubMed ID: 7477382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of thrombin's procoagulant and anticoagulant properties.
    Leung LL; Gibbs CS
    Thromb Haemost; 1997 Jul; 78(1):577-80. PubMed ID: 9198219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric changes in thrombin's activity produced by peptides corresponding to segments of natural inhibitors and substrates.
    Hortin GL; Trimpe BL
    J Biol Chem; 1991 Apr; 266(11):6866-71. PubMed ID: 1849894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface.
    Esmon CT
    FASEB J; 1995 Jul; 9(10):946-55. PubMed ID: 7615164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex.
    Fuentes-Prior P; Iwanaga Y; Huber R; Pagila R; Rumennik G; Seto M; Morser J; Light DR; Bode W
    Nature; 2000 Mar; 404(6777):518-25. PubMed ID: 10761923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of the possible recognition sites for thrombomodulin, procoagulant, and anticoagulant proteins around the active center of alpha-thrombin.
    Nishioka J; Taneda H; Suzuki K
    J Biochem; 1993 Jul; 114(1):148-55. PubMed ID: 8407867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Energetics of thrombin-thrombomodulin interaction.
    Vindigni A; White CE; Komives EA; Di Cera E
    Biochemistry; 1997 Jun; 36(22):6674-81. PubMed ID: 9184147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombin-resistant prothrombin Yukuhashi mutation also causes thrombomodulin resistance in fibrinogen clotting but not in protein C activation.
    Takagi Y; Kato I; Ando Y; Nakamura Y; Murata M; Takagi A; Murate T; Kojima T
    Thromb Res; 2014 Oct; 134(4):914-7. PubMed ID: 25149909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosite 2-Directed Ligands Attenuate Protein C Activation by the Thrombin-Thrombomodulin Complex.
    Chen K; Stafford AR; Wu C; Yeh CH; Kim PY; Fredenburgh JC; Weitz JI
    Biochemistry; 2017 Jun; 56(24):3119-3128. PubMed ID: 28549218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein engineering thrombin for optimal specificity and potency of anticoagulant activity in vivo.
    Tsiang M; Paborsky LR; Li WX; Jain AK; Mao CT; Dunn KE; Lee DW; Matsumura SY; Matteucci MD; Coutré SE; Leung LL; Gibbs CS
    Biochemistry; 1996 Dec; 35(51):16449-57. PubMed ID: 8987977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational engineering of activity and specificity in a serine protease.
    Dang QD; Guinto ER; di Cera E
    Nat Biotechnol; 1997 Feb; 15(2):146-9. PubMed ID: 9035139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of acetylthrombin on protein C activation and fibrinogen clotting.
    Nakagomi K; Ajisaka K; Yokota I
    Thromb Res; 1990 Aug; 59(4):713-22. PubMed ID: 1964250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single amino acid substitutions dissociate fibrinogen-clotting and thrombomodulin-binding activities of human thrombin.
    Wu QY; Sheehan JP; Tsiang M; Lentz SR; Birktoft JJ; Sadler JE
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6775-9. PubMed ID: 1650482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates.
    Hanson SR; Griffin JH; Harker LA; Kelly AB; Esmon CT; Gruber A
    J Clin Invest; 1993 Oct; 92(4):2003-12. PubMed ID: 8408654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Leu99 of thrombin in determining the P2 specificity of serpins.
    Rezaie AR
    Biochemistry; 1997 Jun; 36(24):7437-46. PubMed ID: 9200692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric modulation of BPTI interaction with human alpha- and zeta-thrombin.
    De Cristofaro R; Landolfi R
    Eur J Biochem; 1999 Feb; 260(1):97-102. PubMed ID: 10091588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium-dependent activation of protein C by thrombin/thrombomudulin: role of negatively charged amino acids within the activation peptide of protein C.
    Friedrich U; Pötzsch B; Preissner KT; Müller-Berghaus G; Ehrlich H
    Thromb Haemost; 1994 Oct; 72(4):567-72. PubMed ID: 7878634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tryptophans 231 and 234 in protein C report the Ca(2+)-dependent conformational change required for activation by the thrombin-thrombomodulin complex.
    Rezaie AR; Esmon CT
    Biochemistry; 1995 Sep; 34(38):12221-6. PubMed ID: 7547963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.